Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results

WILMINGTON, Del.--(BUSINESS WIRE)-- Eleventh paragraph, first and second sentences of release dated February 28, 2024 should read: At December 31, 2023, the Company maintained cash and cash equivalents of $1.2 billion; it has restricted cash and restricted cash equivalents of $604 million primarily relating to the U.S. public water district settlement.